Home United States Bills
Bills

United States Bills

Track legislation and stay informed about the bills that matter to you.

Bill results

passed · United States · Senate May 24, 2021

SRES 230: A resolution congratulating the students, parents, teachers, and leaders of charter schools across the United States for making ongoing contributions to education, and supporting the ideals and goals of the 22nd annual National Charter Schools Week, to be held May 9 through May 15, 2021.

This resolution congratulates the students, families, teachers, administrators, and staff of public charter schools across the United States for (1) making ongoing contributions to public education, (2) making impressive strides in closing the academic achievement gap in U.S. schools, and (3) improving and strengthening the public school system. The resolution supports the ideals and goals of the 22nd annual National Charter Schools Week.
Tim Scott (R) · 22 co-sponsors
passed · United States · House May 20, 2021

HR 1629: Fairness in Orphan Drug Exclusivity Act

Fairness in Orphan Drug Exclusivity Act This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats. The sponsor of an FDA-designated orphan drug may be granted various incentives, such as a seven-year period in which the FDA may not grant market approval to a different sponsor for the same drug to treat the same disease.) Under this bill, if a drug is designated as an orphan drug on the basis that there is no reasonable expectation that the sponsor will recover the costs of developing and distributing the drug from U.S. sales, the drug shall be granted the seven-year exclusivity period only if the sponsor demonstrates that there is no reasonable expectation that it will recover such costs specifically within its first 12 years of U.S. sales of the drug. This requirement shall also apply retroactively to an orphan drug that was granted such an exclusivity period before this bill's enactment. When deciding whether an orphan drug meets this requirement, the FDA shall consider the sales of all drugs from the sponsor that are covered by the same orphan drug designation.
Madeleine Dean (D) · 2 co-sponsors
passed · United States · Senate May 19, 2021

SRES 97: A resolution calling on the Government of Ethiopia, the Tigray People's Liberation Front, and other belligerents in the conflict in the Tigray Region of Ethiopia to cease all hostilities, protect human rights, allow unfettered humanitarian access, and cooperate with independent investigations of credible atrocity allegations.

This resolution calls for the immediate cessation of hostilities in the Tigray region of Ethiopia and condemns all violence against civilians. Further, the resolution calls on Eritrea to withdraw its military forces from Ethiopia, and it urges all parties to the conflict to cease hostilities and work to protect human rights. The resolution also calls on relevant U.S. agencies to take specified actions that encourage an end to the conflict and provide humanitarian support.
James E. Risch (R) · 17 co-sponsors
passed · United States · House May 19, 2021

HRES 409: Providing for consideration of the bill (H.R. 3233) to establish the National Commission to Investigate the January 6 Attack on the United States Capitol Complex, and for other purposes; and providing for consideration of the bill (H.R. 3237) making emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.

This resolution sets forth the rule for consideration of H.R. 3233 (National Commission to Investigate the January 6 Attack on the United States Capitol Complex Act) and H.R. 3237 (Emergency Security Supplemental to Respond to January 6th Appropriations Act, 2021).
James P. McGovern (D)
passed · United States · House May 19, 2021

HR 3146: SAVE Act of 2021

Securing America's Vaccines for Emergencies Act of 2021 or the SAVE Act of 2021 This bill authorizes the President to make payments to manufacturers to increase supply-chain security if doing so is important to the national defense. The President must submit a strategy to Congress that includes (1) a plan to use authorities under the Defense Production Act of 1950 to ensure the supply of medical materials essential to the national defense; and (2) plans to diversify, and address vulnerabilities in, supply chains for essential medical materials. The President must submit to Congress annual progress reports through FY2025 evaluating the implementation of the strategy.
J. French Hill (R) · 1 co-sponsor
passed · United States · House May 19, 2021

HR 3125: COVID-19 Emergency Medical Supplies Enhancement Act of 2021

COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Juan Vargas (D) · 4 co-sponsors
passed · United States · House May 19, 2021

HR 3008: Homebuyer Assistance Act of 2021

Homebuyer Assistance Act of 2021 This bill modifies requirements for appraisers of Federal Housing Administration-insured mortgages. Currently, an appraiser must be certified by certain state or national entities. The bill removes the national entities from the list of approved certification entities and allows an appraiser for a mortgage for single-family housing to be state-licensed rather than state-certified to meet requirements. The bill also provides specified educational requirements for appraisers for mortgages for single-family housing.
Brad Sherman (D) · 1 co-sponsor
passed · United States · House May 19, 2021

HR 2959: COVID-19 Fraud Prevention Act

COVID-19 Fraud Prevention Act This bill establishes the Consumer and Investor Fraud Working Group to prevent fraud during the COVID-19 (i.e., coronavirus disease 2019) pandemic. The working group must report quarterly regarding resources available to consumers, public enforcement actions, and related consumer complaints.
Cynthia Axne (D) · 1 co-sponsor
Showing 4,033 to 4,044 of 4,304 bills